PHI with Pancreatic cancer
How does this condition affect your private health insurance?
Bauchspeicheldrüsenkrebs, oder Pankreaskarzinom, ist ein bösartiger Tumor, der von den Zellen der Bauchspeicheldrüse ausgeht. Er ist bekannt für seine aggressive Natur und wird oft erst in fortgeschrittenen Stadien diagnostiziert, da frühe Symptome wie unspezifische Bauchschmerzen, Gewichtsverlust oder neu auftretender Diabetes häufig übersehen werden. Dies trägt maßgeblich zur schlechten Prognose bei. Die häufigste Form ist das duktale Adenokarzinom. Die Behandlung umfasst in der Regel Chirurgie, Chemotherapie und Strahlentherapie, ist aber stark vom Stadium der Erkrankung abhängig. Die Früherkennung ist entscheidend, aber selten.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months from symptom onset until diagnosis and initiation of initial treatment.
Duration of Illness (Lifetime)
Chronic and progressive, typically leading to a significantly shortened lifespan due to its aggressive nature and high mortality rate.
Cost of Treatment (Initial)
High (e.g., tens to hundreds of thousands of USD/EUR for initial diagnostics, surgery, and first rounds of chemotherapy/radiation).
Cost of Treatment (Lifetime)
Very high (e.g., hundreds of thousands to over a million USD/EUR), including continuous chemotherapy, radiation, supportive care, pain management, and complication treatment.
Mortality Rate
Very high, with 5-year survival rates typically below 10-15% for all stages combined, making it one of the deadliest cancers.
Risk of Secondary Damages
High; includes severe pain, malabsorption, diabetes mellitus, jaundice, cachexia (wasting syndrome), deep vein thrombosis, depression, and anxiety.
Probability of Full Recovery
Very low; complete cure is rare and primarily achieved only in very early-stage, completely resectable cases without lymph node involvement or metastasis.
Underlying Disease Risk
Moderate to high; risk factors include chronic pancreatitis, diabetes mellitus, obesity, smoking, and certain genetic syndromes. New-onset diabetes can also be a symptom of pancreatic cancer.